Epsom, United Kingdom

William Skinner Maclachlan

This inventor holds 1 USPTO granted patent. Top assignee: Beecham Group Plc. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Skinner Maclachlan. Retrieved from https://idiyas.com/inventor/william-skinner-maclachlan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: William Skinner Maclachlan: Innovator in Pharmaceutical Chemistry

Introduction

William Skinner Maclachlan is a notable inventor based in Epsom, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on amphotericin derivatives. His research has the potential to impact the treatment of various medical conditions.

Latest Patents

Maclachlan holds a patent for amphotericin derivatives, specifically a compound of formula (I), or a pharmaceutically acceptable salt thereof. This patent represents his commitment to advancing pharmaceutical science and improving therapeutic options.

Career Highlights

Throughout his career, Maclachlan has been associated with Beecham Group Plc, a prominent company in the pharmaceutical industry. His work there has allowed him to collaborate with other experts and contribute to the development of new medical solutions.

Conclusion

William Skinner Maclachlan's contributions to pharmaceutical chemistry, particularly through his patent on amphotericin derivatives, highlight his role as an innovator in the field. His work continues to influence the development of effective treatments in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…